InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,614.53
(
0.67%
)
US TECH 100
20,081.20
(
0.86%
)
Dow Jones
39,483.99
(
0.49%
)
Brent Oil
84.67
(
-0.04%
)
Bitcoin
57,617.38
(
-0.69%
)
Post# of 21540
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Cyosol

Send PM Follow Ignore
Followers 2
Posts 1360
Boards Moderated 0
Alias Born 01/05/2018

Cyosol

Re: runncoach post# 17231

Tuesday, 06/01/2021 10:53:08 AM

Tuesday, June 01, 2021 10:53:08 AM

Post# of 21540
Reading about the patients hoping for an aducanumab approval makes me sad. They deserve an actual cure, not another expensive drug that barely (if at all) slows the decline and extends their suffering.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SNPX News
More SNPX News
InvestorsHub NewsWire

FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM

Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM

Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!